Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 11 studies | 21% ± 4% | |
retinal rod cell | 6 studies | 27% ± 6% | |
fibroblast | 6 studies | 21% ± 6% | |
retinal cone cell | 5 studies | 26% ± 6% | |
epithelial cell | 5 studies | 28% ± 17% | |
pericyte | 5 studies | 21% ± 5% | |
adipocyte | 4 studies | 24% ± 7% | |
Mueller cell | 4 studies | 27% ± 7% | |
hepatocyte | 4 studies | 51% ± 25% | |
astrocyte | 4 studies | 27% ± 7% | |
GABAergic neuron | 4 studies | 27% ± 6% | |
glutamatergic neuron | 4 studies | 30% ± 9% | |
oligodendrocyte precursor cell | 4 studies | 16% ± 1% | |
macrophage | 4 studies | 25% ± 7% | |
retina horizontal cell | 3 studies | 19% ± 3% | |
retinal bipolar neuron | 3 studies | 23% ± 6% | |
rod bipolar cell | 3 studies | 27% ± 4% | |
retinal pigment epithelial cell | 3 studies | 28% ± 15% | |
CD4-positive, alpha-beta T cell | 3 studies | 23% ± 10% | |
dendritic cell | 3 studies | 23% ± 6% | |
endothelial cell of vascular tree | 3 studies | 25% ± 11% | |
transit amplifying cell | 3 studies | 30% ± 9% | |
interneuron | 3 studies | 30% ± 14% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 1106.70 | 1443 / 1445 | 99% | 16.02 | 181 / 183 |
intestine | 100% | 1639.17 | 966 / 966 | 99% | 17.43 | 520 / 527 |
stomach | 100% | 1121.78 | 359 / 359 | 99% | 19.11 | 282 / 286 |
liver | 100% | 2191.76 | 226 / 226 | 98% | 13.72 | 398 / 406 |
adrenal gland | 100% | 1944.65 | 258 / 258 | 98% | 9.00 | 225 / 230 |
uterus | 100% | 2108.09 | 170 / 170 | 97% | 10.96 | 444 / 459 |
pancreas | 100% | 935.27 | 328 / 328 | 97% | 7.30 | 172 / 178 |
prostate | 100% | 1848.16 | 245 / 245 | 96% | 6.58 | 480 / 502 |
brain | 96% | 719.89 | 2548 / 2642 | 98% | 7.60 | 691 / 705 |
lung | 100% | 2092.92 | 577 / 578 | 92% | 7.83 | 1057 / 1155 |
kidney | 100% | 1436.02 | 89 / 89 | 90% | 6.58 | 809 / 901 |
bladder | 100% | 1395.52 | 21 / 21 | 88% | 10.12 | 443 / 504 |
thymus | 100% | 1378.62 | 651 / 653 | 88% | 4.77 | 532 / 605 |
ovary | 100% | 4392.89 | 180 / 180 | 85% | 5.09 | 366 / 430 |
skin | 100% | 1474.77 | 1808 / 1809 | 79% | 6.62 | 371 / 472 |
breast | 100% | 1979.07 | 459 / 459 | 75% | 5.81 | 844 / 1118 |
adipose | 100% | 2076.02 | 1204 / 1204 | 0% | 0 | 0 / 0 |
muscle | 100% | 1487.65 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 1616.54 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 2.16 | 1 / 1 |
blood vessel | 100% | 1382.28 | 1331 / 1335 | 0% | 0 | 0 / 0 |
heart | 96% | 870.18 | 830 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 93% | 8.53 | 42 / 45 |
lymph node | 0% | 0 | 0 / 0 | 62% | 3.34 | 18 / 29 |
eye | 0% | 0 | 0 / 0 | 53% | 3.07 | 42 / 80 |
peripheral blood | 22% | 199.46 | 201 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0045892 | Biological process | negative regulation of DNA-templated transcription |
GO_0005634 | Cellular component | nucleus |
GO_0042393 | Molecular function | histone binding |
GO_0003682 | Molecular function | chromatin binding |
Gene name | SCML1 |
Protein name | Sex comb on midleg-like protein 1 Scm polycomb group protein like 1 |
Synonyms | |
Description | FUNCTION: Putative Polycomb group (PcG) protein. PcG proteins act by forming multiprotein complexes, which are required to maintain the transcriptionally repressive state of homeotic genes throughout development. May be involved in spermatogenesis during sexual maturation (By similarity). . |
Accessions | Q9UN30 ENST00000380043.7 [Q9UN30-2] ENST00000419185.1 ENST00000380045.7 [Q9UN30-1] Q5H966 ENST00000380041.8 [Q9UN30-3] ENST00000398080.5 [Q9UN30-1] |